PMDSF (Pharma Foods International Co) ROC (Joel Greenblatt) %: 4.13% (As of Jan. 2026) — 84% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PMDSF Pharma Foods International Co Ltd PMDSF
63 GF Score
Price $6.40
GF Value $11.44
! 5 Warning Signs
View Full Analysis

What is Pharma Foods International Co ROC (Joel Greenblatt) %?

Pharma Foods International Co PMDSF 63 ROC (Joel Greenblatt) % is 4.13% as of Jan. 2026, which is 84% below its 10-year median of 25.52. GuruFocus rates PMDSF with a GF Score™ of 63/100 and a GF Value™ of $11.44. The stock has 5 warning signs investors should review. Among 981 Drug Manufacturers companies, Pharma Foods International Co ranks worse than 77.37% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Pharma Foods International Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was 4.13%.

The historical rank and industry rank for Pharma Foods International Co's ROC (Joel Greenblatt) % or its related term are showing as below:

PMDSF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -12.74   Med: 25.52   Max: 170.69
Current: -12.74

During the past 13 years, Pharma Foods International Co's highest ROC (Joel Greenblatt) % was 170.69%. The lowest was -12.74%. And the median was 25.52%.

PMDSF's ROC (Joel Greenblatt) % is ranked worse than
77.37% of 981 companies
in the Drug Manufacturers industry
Industry Median: 11.53 vs PMDSF: -12.74

Pharma Foods International Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -8.20% per year.


Pharma Foods International Co  (OTCPK:PMDSF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Pharma Foods International Co ROC (Joel Greenblatt) % Related Terms


Pharma Foods International Co ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Pharma Foods International Co's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Foods International Co ROC (Joel Greenblatt) % Chart

Pharma Foods International Co Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.12 18.72 31.93 52.39 25.89

Pharma Foods International Co Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Jul25 Oct25 Jan26 Apr26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.61 0.00 -91.68 4.13 28.60

PMDSF vs ZTS, UTHR: ROC (Joel Greenblatt) % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Foods International Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Foods International Co ROC (Joel Greenblatt) % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharma Foods International Co's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Pharma Foods International Co's ROC (Joel Greenblatt) % falls into.


PMDSF
63GF Score
Pharma Foods International Co Ltd PMDSF
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Foods International Co ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Oct. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(28.562 + 55.347 + 9.811) - (46.678 + 0 + 5.101)
=41.941

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(27.628 + 58.966 + 6.983) - (42.279 + 0 + 3.722)
=47.576

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Pharma Foods International Co for the quarter that ended in Jan. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Jan. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2025  Q: Jan. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3.14/( ( (31.615 + max(41.941, 0)) + (30.878 + max(47.576, 0)) )/ 2 )
=3.14/( ( 73.556 + 78.454 )/ 2 )
=3.14/76.005
=4.13 %

Note: The EBIT data used here is four times the quarterly (Jan. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 4.13% mean?
Pharma Foods International Co (PMDSF) has a ROC (Joel Greenblatt) % of 4.13% as of Jan. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Pharma Foods International Co and its competitors. This is 84% below median its historical median of 25.52. According to the industry distribution chart, Pharma Foods International Co ranks #759 out of 981 companies in the Drug Manufacturers industry, placing it in the top 77.4%.
Is Pharma Foods International Co's ROC (Joel Greenblatt) % too high?
Pharma Foods International Co's current ROC (Joel Greenblatt) % of 4.13% is 84% below median its 10-year median of 25.52. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 11.53. Pharma Foods International Co's value of 4.13% is 64.2% below this industry median. Based on the distribution chart, Pharma Foods International Co ranks #759 out of 981 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Pharma Foods International Co has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Pharma Foods International Co's ROC (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Pharma Foods International Co ranks #759 out of 981 companies for ROC (Joel Greenblatt) %. This places Pharma Foods International Co in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 11.53. Pharma Foods International Co's value of 4.13% is 64.2% below this benchmark. While the company's 10-year median is 25.52 vs. the industry median of 11.53, Pharma Foods International Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.53, based on 981 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma Foods International Co's current ROC (Joel Greenblatt) % of 4.13% is 64.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Pharma Foods International Co and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Foods International Co's current ROC (Joel Greenblatt) % is 4.13%, which is 84% below median its own 10-year median of 25.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Foods International Co stock overvalued right now?
Pharma Foods International Co (PMDSF) has a current ROC (Joel Greenblatt) % of 4.13%. The stock's GF Value™ is $11.44, compared to a current price of $6.40 — trading 44.1% below its estimated fair value. The current ROC (Joel Greenblatt) % is 4.13%, which is 84% below median its 10-year median of 25.52 and 64.2% below the Drug Manufacturers industry median of 11.53. Pharma Foods International Co's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Pharma Foods International Co (PMDSF), the current ROC (Joel Greenblatt) % is 4.13% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Foods International Co (PMDSF) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Foods International Co stock appears to be undervalued. The current stock price of $6.40 is trading 44.1% below its estimated GF Value™ of $11.44.

Key valuation signals for PMDSF:

  • ROC (Joel Greenblatt) %: 4.13% (84% below median its 10-year median of 25.52)
  • GF Value™: $11.44 vs. price of $6.40 (44.1% below fair value)
  • GF Score™: 63/100 with 5 warning signs
  • Industry Position: 64.2% below the Drug Manufacturers median (#759 of 981)

No single metric tells the full story. See the PMDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma Foods International Co Business Description

Other Exchanges 2929:Japan
Address 1-49 Ohara Kyoto imperial tomb Saikyo-ku, Kyoto, JPN, 615-8245
Pharma Foods International Co Ltd is engaged in the development and sales of functional food materials.
63GF Score

Get the complete analysis for PMDSF

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.40
Price
$11.44
GF Value